Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 3, 2012, Pages 847-850

  Liu, Ke ^a   Qin, Cheng Kun ^a   Wang, Zhi Yi ^a   Liu, Su Xia ^b   Cui, Xian Ping ^a   Zhang, Dong Yuan ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

EGFR; Immunohistochemistry; Pancreatic cancer; TNFAIP8

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; SIGNAL PEPTIDE; TNFAIP8 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE COURSE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PANCREATITIS; PATHOLOGY;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871696211     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.3.847     Document Type: Article

References (16)

1. Aggarwal S, Gupta S, Gupta MK, et al (2011). Possible role of epidermal growth factor receptors in the therapy of pancreatic cancer. Crit Rev Ther Drug Carrier Syst, 28, 293-356.
2. Azizi A, Naguib NN, Mbalisike E, et al (2011). Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival. Pancreas, 40, 1271-5.
3. Dong QZ, Zhao Y, Liu Y, et al (2010). Overexpression of SCC-S2 correlates with lymph node metastasis and poor prognosis in patients with non-small-cell lung. Cancer Sci, 101, 1562-9.
4. Freundt EC, Bidere N, Lenardo MJ (2008). A different TIPE of immune homeostasis. Cell, 133, 401-2.
5. Hong SM, Park JY, Hruban RH, et al (2011). Molecular signatures of pancreatic cancer. Arch Pathol Lab Med, 135, 716-27.
6. Ioannou N, Dalgleish AG, Seddon AM, et al (2011). Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells. Br J Cancer, 105, 1554-62.
7. Kumar D, Whiteside TL, Kasid U (2000). Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin- 1beta-converting enzyme-inhibitory protein. J Biol Chem, 275, 2973-8.
8. Kumar D, Gokhale P, Broustas C et al (2004). Expression of SCC-S2, a antiapoptotic molecule, correlates with enhanced proliferation antumorigenicity of MDA-MB 435 cells. Oncogene, 23, 612-6.
9. Patel S, Wang FH, Whiteside TL, et al(1997). Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol, 33, 197-203.
10. Romanuik TL, Ueda T, Le N, et al (2009). Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol, 175, 2264-76.
11. Sharma C, Eltawil KM, Renfrew PD, et al (2011). Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol, 17, 867-97.
12. Sun H, Gong S, Carmody RJ, et al (2008). TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell, 133, 415-26.
13. Vincent A, Herman J, Schulick R, et al (2011). Pancreatic cancer. Lancet, 378, 607-20.
14. Xu S, Weihua Z (2011). Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin. Prostate, 71, 1216-24.
15. You Z, Ouyang H, Lopatin D, et al (2001). Nuclear factorkappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem, 276, 26398-404.
16. Zhang C, Chakravarty D, Sakabe I, et al (2006). Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther, 13, 947-55.